| Literature DB >> 23298461 |
Zhi-Ling Zhang1, Yong-Hong Li, Jun-Hang Luo, Zhuo-Wei Liu, Kai Yao, Pei Dong, Hui Han, Zi-Ke Qin, Wei Chen, Fang-Jian Zhou.
Abstract
The reporting of complications following transperitoneal and retroperitoneal open radical nephrectomy (RN) is nonstandardized. This study aimed to compare early complications between the two approaches using a standardized reporting methodology in a large contemporary cohort. Between 1996 and 2009, 558 patients underwent open RN for renal cell carcinoma (RCC) in our two centers (424 from Sun Yat-sen University Cancer Center and 134 from the First Affiliated Hospital of Sun Yat-sen University). Records were reviewed for clinicopathologic features and complications. Complications were graded using the Clavien system based on the severity of impact. One hundred and five patients (18.8%) had one or more early complications (168 complications overall). The overall rates of grades I to V complications were 5.6%, 10.8%, 2.2%, 0.4%, and 0.2%, respectively. Patients who underwent transperitoneal RN did not experience more overall or procedure-related complications than those who underwent retroperitoneal RN (P = 0.911 and P = 0.851, respectively). On subgroup analysis, neither grade I/II nor grades III-V complications were significantly different between the transperitonal RN and retroperitoneal RN groups. Multivariate analysis showed that for any grade of complication, age (P = 0.016) and estimated blood loss (P = 0.001) were significant predictors. We concluded that open RN is a safe procedure associated with low rates of serious morbidity and mortality. Compared with retroperitoneal RN, transperitoneal RN was not associated with more complications. Older patient and more blood loss at surgery were independent predictors for higher early postoperative complication rates.Entities:
Mesh:
Year: 2013 PMID: 23298461 PMCID: PMC3845581 DOI: 10.5732/cjc.012.10185
Source DB: PubMed Journal: Chin J Cancer ISSN: 1944-446X
Clinical features, intraoperative data, and hospitalization duration of 568 patients with renal cell cancer
| Characteristic | Total | TPRN (n = 347) | RTPRN (n = 211) | |
| Median age (years, range) | 52 (4-83) | 53 (4-83) | 52 (12-79) | 0.476 |
| Male patients (n, %) | 360 (64.5) | 220 (63.4) | 140 (66.4) | 0.523 |
| Left-sided tumors (n, %) | 281 (50.4) | 176 (50.7) | 105 (49.8) | 0.914 |
| ASA score (n, %) | 0.001 | |||
| 1 | 243 (43.5) | 150 (43.2) | 93 (44.1) | |
| 2 | 137 (24.6) | 69 (19.9) | 68 (32.2) | |
| 3 | 146 (26.2) | 103 (29.7) | 43 (20.4) | |
| 4 | 32 (5.7) | 25 (7.2) | 7 (3.3) | |
| Patients with prior abdominal surgery (n, %) | 41 (7.3) | 26 (7.5) | 15 (7.1) | 1.000 |
| Mean body-mass index (kg/m2, range) | 23.3 (14.0-39.0) | 23.0 (14.0-39.0) | 23.9 (16.9-36.2) | 0.008 |
| Overweight (body-mass index >25 kg/m2) (n, %) | 168 (30.1) | 92 (26.5) | 76 (36.0) | 0.022 |
| Median tumor size (cm, interquartile range) | 5.5 (4.0-8.0) | 6.0 (5.0-9.0) | 4.9 (3.0-6.0) | <0.001 |
| T category (n, %) | <0.001 | |||
| T1a | 151 (27.1) | 62 (17.9) | 89 (42.2) | |
| T1b | 198 (35.5) | 113 (32.6) | 85 (40.3) | |
| T2 | 125 (22.4) | 96 (27.7) | 29 (13.7) | |
| T3-T4 | 84 (15.1) | 76 (21.9) | 8 (3.8) | |
| N category (n, %) | <0.001 | |||
| N0 | 329 (59.0) | 234 (67.4) | 95 (45.0) | |
| N1+2 | 53 (9.5) | 43 (12.4) | 10 (4.7) | |
| Nx | 176 (31.5) | 70 (20.2) | 106 (50.2) | |
| M category (n, %) | 0.001 | |||
| M0 | 504 (90.3) | 302 (87.0) | 202 (95.7) | |
| M1 | 54 (10.4) | 45 (13.0) | 9 (4.3) | |
| Median operative time (min, interquartile range) | 155 (120-185) | 155 (121-189) | 150 (120-185) | 0.915 |
| Median length of hospital stay (days, interquartile range) | 9 (7-11) | 9 (7-12) | 9 (8-11) | 0.910 |
| Reoperation (n, %) | 6 (1.1) | 4 (1.2) | 2 (0.9) | 1.000 |
| Complication-related deaths (n, %) | 1 (0.2) | 1 (0.3) | 0 (0) | 1.000 |
| Median estimated blood loss (mL, interquartile range) | 150 (100-300) | 200 (100-350) | 150 (100-200) | 0.001 |
| Transfusion required (n, %) | 40 (7.2) | 28 (8.1) | 12 (5.7) | 0.315 |
TPRN, transperitoneal radical nephrectomy; RTPRN, retroperitoneal radical nephrectomy; ASA, American Society of Anesthesiologists.
Overall postoperative complication data of 568 patients with renal cell cancer
| Complication | Total | TPRN (n = 347) | RTPRN (n = 211) | |
| Patients with complications (n, %) | 105 (18.8) | 66 (19.0) | 39 (18.5) | 0.911 |
| Total number of complications | 168 | 108 | 60 | 0.568 |
| Grade I/II complications (n, %) | 91 (16.3) | 57 (16.4) | 34 (16.1) | 1.000 |
| Grade I | 31 (5.6) | 16 (4.6) | 15 (7.1) | |
| Grade II | 60 (10.8) | 41 (11.8) | 19 (9.0) | |
| Grades III-V complications (n, %) | 14 (2.5) | 9 (2.6) | 5 (2.4) | 1.000 |
| Grade III | 11 (2.2) | 7 (2.0) | 4 (1.9) | |
| Grade IV | 2 (0.4) | 1 (0.3) | 1 (0.5) | |
| Grade V | 1 (0.2) | 1 (0.3) | 0 | |
| Gastrointestinal (23.8%, n = 40) | 40 | 27 | 13 | 0.504 |
| Ileus | 8 | 8 | 0 | |
| SBO | 1 | 1 | 0 | |
| Diarrhea | 9 | 5 | 4 | |
| Fistula, intestinal | 2 | 1 | 1 | |
| Constipation | 5 | 2 | 3 | |
| Emesis | 7 | 4 | 3 | |
| Colitis | 3 | 1 | 2 | |
| Chylous ascites | 5 | 5 | 0 | |
| Infectious (10.7%, n = 18) | 18 | 15 | 3 | 0.082 |
| Fever | 15 | 14 | 1 | |
| Sepsis | 1 | 0 | 1 | |
| Cholecystitis | 2 | 1 | 1 | |
| Wound (3.6%, n = 6) | 6 | 4 | 2 | 0.312 |
| Seroma | 6 | 4 | 2 | |
| Genitourinary (11.3%, n = 19) | 19 | 9 | 10 | 0.228 |
| Renal failure | 16 | 9 | 7 | |
| Urinary retention | 3 | 0 | 3 | |
| Cardiac (10.7%, n = 18) | 18 | 11 | 7 | 1.000 |
| Arrhythmia | 8 | 5 | 3 | |
| Hypotension | 6 | 2 | 4 | |
| Congestive heart failure | 3 | 3 | 0 | |
| Angina | 1 | 1 | 0 | |
| Pulmonary (13.7%, n = 23) | 23 | 12 | 11 | 0.380 |
| Atelectasis | 1 | 1 | 0 | |
| Pneumonia | 7 | 3 | 4 | |
| Respiratory distress | 3 | 2 | 1 | |
| Pneumothorax | 4 | 2 | 2 | |
| Pleural effusion | 8 | 4 | 4 | |
| Bleeding (15.5%, n = 26) | 26 | 19 | 7 | 0.302 |
| Postoperative bleed other than gastrointestinal | 6 | 4 | 2 | |
| Anemia requiring transfusion | 20 | 15 | 5 | |
| Thromboembolic (5.4%, n = 9) | 9 | 8 | 1 | 0.164 |
| Deep venous thrombosis | 1 | 1 | 0 | |
| Pulmonary embolus | 1 | 1 | 0 | |
| Superficial phlebitis | 1 | 1 | 0 | |
| Thrombocytopenia | 6 | 5 | 1 | |
| Neurological (2.4%, n = 4) | 4 | 2 | 2 | 0.635 |
| Vertigo | 1 | 0 | 1 | |
| Loss of consciousness | 1 | 1 | 0 | |
| Seizure | 2 | 1 | 1 | |
| Others (3.0%, n = 5) | 5 | 1 | 4 | 0.070 |
| Acidosis | 1 | 0 | 1 | |
| Rash | 4 | 1 | 3 |
TPRN, transperitoneal radical nephrectomy; RTPRN, retroperitoneal radical nephrectomy; ASA, American Society of Anesthesiologists.
Procedure-related complications in patients treated with TPRN and RTPRN
| Complication | Total | Grade | |||
| I | II | III | IV | ||
| TPRN (n, %) | 21 (6.1) | 6 (1.7) | 9 (2.6) | 5 (1.4) | 1 (0.3) |
| Retroperitoneal hemorrhage | 4 | 0 | 0 | 3 | 1 |
| Fistula, intestinal | 1 | 0 | 0 | 1 | 0 |
| Bowel obstruction | 8 | 0 | 8 | 0 | 0 |
| Acute renal failure | 9 | 8 | 0 | 1 | 0 |
| Chylous ascites | 5 | 0 | 4 | 1 | 0 |
| Pneumothorax | 2 | 0 | 0 | 2 | 0 |
| Total | 29 | 8 | 12 | 8 | 1 |
| RTPRN (n, %) | 11 (5.2) | 7 (3.3) | 1 (0.5) | 2 (0.9) | 1 (0.5) |
| Retroperitoneal hemorrhage | 2 | 0 | 1 | 1 | 0 |
| Fistula, intestinal | 1 | 0 | 0 | 0 | 1 |
| Acute renal failure | 7 | 7 | 0 | 0 | 0 |
| Pneumothorax | 2 | 1 | 0 | 1 | 0 |
| Total | 12 | 8 | 1 | 2 | 1 |
TPRN, transperitoneal radical nephrectomy; RTPRN, retroperitoneal radical nephrectomy. All values are presented as the number of patients.
Logistic regression analysis of variables associated with early complications
| Variable | Univariate analysis | Multivariate | ||||
| OR | 95% CI | OR | 95% CI | |||
| Early postoperative complications | ||||||
| Age | 1.023 | 1.006-1.040 | 0.008 | 1.021 | 1.004-1.038 | 0.016 |
| Sex | 1.250 | 0.794-1.969 | 0.336 | 1.064 | 0.664-1.705 | 0.797 |
| ASA score | 1.316 | 1.060-1.633 | 0.013 | 1.129 | 0.853-1.494 | 0.396 |
| Body-mass index | 1.045 | 0.986-1.108 | 0.138 | 1.038 | 0.976-1.104 | 0.241 |
| Prior abdominal surgery | 0.579 | 0.222-1.513 | 0.265 | 0.495 | 0.182-1.350 | 0.170 |
| Tumor size | 1.004 | 0.998-1.010 | 0.204 | 1.002 | 0.994-1.010 | 0.650 |
| Tumor side | 1.000 | 0.728-1.374 | 0.999 | 1.003 | 0.723-1.392 | 0.985 |
| Stage | 1.131 | 0.931-1.375 | 0.215 | 0.943 | 0.721-1.235 | 0.671 |
| Operative time | 1.004 | 1.001-1.008 | 0.012 | 1.002 | 0.998-1.006 | 0.411 |
| Estimated blood loss | 1.001 | 1.000-1.001 | 0.001 | 1.001 | 1.000-1.001 | 0.001 |
| Surgical approach | 1.036 | 0.668-1.607 | 0.875 | 0.904 | 0.556-1.470 | 0.685 |
| Procedure-related complications | ||||||
| Age | 1.011 | 0.984-1.038 | 0.443 | 1.007 | 0.974-1.041 | 0.686 |
| Sex | 1.053 | 0.497-2.232 | 0.893 | 0.807 | 0.367-1.774 | 0.594 |
| ASA score | 1.311 | 0.917-1.876 | 0.138 | 1.110 | 0.691-1.783 | 0.666 |
| Body-mass index | 1.011 | 0.916-1.116 | 0.823 | 1.020 | 0.922-1.128 | 0.706 |
| Prior abdominal surgery | 0.392 | 0.052-2.946 | 0.363 | 0.376 | 0.048-2.925 | 0.350 |
| Tumor size | 1.003 | 0.992-1.014 | 0.584 | 0.991 | 0.977-1.005 | 0.198 |
| Tumor side | 0.593 | 0.284-1.236 | 0.163 | 0.583 | 0.270-1.260 | 0.170 |
| Stage | 1.464 | 1.083-1.979 | 0.013 | 1.351 | 0.905-2.016 | 0.141 |
| Operative time | 1.007 | 1.002-1.013 | 0.007 | 1.002 | 0.995-1.008 | 0.628 |
| Estimated blood loss | 1.001 | 1.000-1.001 | 0.001 | 1.001 | 1.000-1.001 | 0.001 |
| Surgical approach | 1.171 | 0.553-2.481 | 0.680 | 0.850 | 0.364-1.985 | 0.707 |
ASA, American Society of Anesthesiologists; BMI, body-mass index; OR, odds ratio; CI, confidence interval.
Reported incidence of postoperative complications of radical nephrectomy
| Investigator | Country | Year | Number of patients | Laparoscopic | Complication rate | TPRN | RTPRN | Standard system |
| Shekarriz | USA | 1991-1997 | 60 | No | 3.3% | NA | NA | No |
| Shuford | USA | 1999-2001 | 41 | No | 10.0% | NA | NA | No |
| Mejean | France | 1986-1997 | 656 | No | 20.9% | NA | NA | No |
| Dunn | Egypt | 1990-1999 | 33 | No | 54.0% | NA | NA | No |
| Hemal | India | 1998-2006 | 71 | No | 15.5% | NA | NA | No |
| Gill | USA | 1997-2000 | 34 | No | 24.0% | NA | NA | No |
| Herranz Amo | Spanish | NA | 109 | No | 24.8% | NA | NA | No |
| Stephenson | USA | 1995-2002 | 688 | No | 16.0% | NA | NA | Yes |
| Joudi | USA | 2000-2003 | 18575 | No | 18.2% | NA | NA | Yes |
| Desai | USA | 1999-2001 | 102 | Yes | 16.7% | 20.0% | 13.5% | No |
| Taue | Japan | NA | 100 | Yes | 9.0% | 4.5% | 9.1% | No |
| Berdjis | Germany | 1999-2003 | 63 | Yes | 9.5% | 11.8% | 7.0% | No |
| Zhang | China | 1999-2009 | 558 | No | 18.8% | 19.0% | 18.5% | Yes |
TPRN, transperitoneal radical nephrectomy; RTPRN, retroperitoneal radical nephrectomy; NA, not available.